{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:15:58Z","timestamp":1778156158214,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clbc.2026.03.010","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:28:58Z","timestamp":1773854938000},"page":"121-129.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subtype-Specific Risk and Temporal Dynamics of Brain Metastases in Metastatic Breast Cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Kyoo Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joohyuk","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Hung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Hyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Ye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Seok","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seho","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gun Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clbc.2026.03.010_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13058-015-0665-1","article-title":"Breast cancer brain metastases: biology and new clinical perspectives","volume":"18","author":"Witzel","year":"2016","journal-title":"Breast Cancer Res"},{"issue":"17","key":"10.1016\/j.clbc.2026.03.010_bib0002","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1200\/JCO.2004.01.175","article-title":"CNS metastases in breast cancer","volume":"22","author":"Lin","year":"2004","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2026.03.010_bib0003","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41416-021-01424-8","article-title":"Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies","volume":"125","author":"Wang","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2026.03.010_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102521","article-title":"Molecular aspects of brain metastases in breast cancer","volume":"114","author":"Tomasik","year":"2023","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"10.1016\/j.clbc.2026.03.010_bib0005","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.jtho.2023.06.017","article-title":"Genomic alterations and the incidence of brain metastases in advanced and metastatic NSCLC: a systematic review and meta-analysis","volume":"18","author":"Gillespie","year":"2023","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2026.03.010_bib0006","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.3747\/co.20.1481","article-title":"Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases","volume":"20","author":"Ali","year":"2013","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clbc.2026.03.010_bib0007","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/annonc\/mdw326","article-title":"Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Novello","year":"2016","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2026.03.010_bib0008","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/neuonc\/noaa285","article-title":"The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis","volume":"23","author":"Kuksis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.clbc.2026.03.010_bib0009","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00432-018-2644-2","article-title":"Patterns of breast cancer relapse in accordance to biological subtype","volume":"144","author":"Ignatov","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"10.1016\/j.clbc.2026.03.010_bib0010","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.asjsur.2021.12.037","article-title":"Brain metastasis in de novo breast cancer: an updated population-level study from SEER database","volume":"45","author":"Sun","year":"2022","journal-title":"Asian J Surg"},{"issue":"12","key":"10.1016\/j.clbc.2026.03.010_bib0011","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41416-019-0619-y","article-title":"Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort","volume":"121","author":"Darlix","year":"2019","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2026.03.010_bib0012","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1470-2045(22)00022-5","article-title":"Medical treatment for active breast cancer brain metastases","volume":"23","author":"Bailleux","year":"2022","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2026.03.010_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25424","article-title":"Analysis of rates of brain metastases and association with breast cancer subtypes in Ontario, Canada","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.clbc.2026.03.010_bib0014","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/OP.23.00794","article-title":"Breast cancer brain metastasis: a comprehensive review","volume":"20","author":"Raghavendra","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.clbc.2026.03.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102324","article-title":"Targeting brain metastases in breast cancer","volume":"103","author":"Corti","year":"2022","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1016\/j.clbc.2026.03.010_bib0016","first-page":"e1274","article-title":"HER2-positive breast cancer brain metastasis: a new and exciting landscape","volume":"5","author":"Zimmer","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"issue":"8","key":"10.1016\/j.clbc.2026.03.010_bib0017","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.molonc.2014.06.006","article-title":"HER2 mediated de novo production of TGF\u03b2 leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancer","volume":"8","author":"Gupta","year":"2014","journal-title":"Mol Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2026.03.010_bib0018","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1158\/0008-5472.CAN-06-3316","article-title":"Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain","volume":"67","author":"Palmieri","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.clbc.2026.03.010_bib0019","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.18632\/oncotarget.2846","article-title":"Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines","volume":"6","author":"Momeny","year":"2015","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.clbc.2026.03.010_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164137","article-title":"Molecular mechanisms associated with brain metastases in HER2-positive and triple negative breast cancers","volume":"13","author":"Bryan","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.clbc.2026.03.010_bib0021","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","article-title":"Metastatic stem cells: sources, niches, and vital pathways","volume":"14","author":"Oskarsson","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.clbc.2026.03.010_bib0022","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1158\/0008-5472.CAN-17-2994","article-title":"Targeting brain-adaptive cancer stem cells prohibits brain metastatic colonization of triple-negative breast cancer","volume":"78","author":"Ren","year":"2018","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.clbc.2026.03.010_bib0023","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s11864-022-01011-w","article-title":"Systemic therapy approaches for breast cancer brain and leptomeningeal metastases","volume":"23","author":"Dhakal","year":"2022","journal-title":"Curr Treat Options Oncol"},{"issue":"22","key":"10.1016\/j.clbc.2026.03.010_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228534","article-title":"Management of brain and leptomeningeal metastases from breast cancer","volume":"21","author":"Pellerino","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.010_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr Oncol Rep"},{"issue":"13","key":"10.1016\/j.clbc.2026.03.010_bib0026","article-title":"Lung cancer with brain metastasis-treatment strategies and molecular characteristics","volume":"23","author":"Wang","year":"2024","journal-title":"J Clin Med"},{"issue":"Suppl 3","key":"10.1016\/j.clbc.2026.03.010_bib0027","doi-asserted-by":"crossref","first-page":"S298","DOI":"10.21037\/tlcr.2019.05.15","article-title":"Brain metastases in oncogene-driven non-small cell lung cancer","volume":"8","author":"Nishino","year":"2019","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.010_bib0028","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lungcan.2007.05.001","article-title":"Detecting extrathoracic metastases in patients with non-small cell lung cancer: is routine scanning necessary?","volume":"58","author":"Metintas","year":"2007","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.clbc.2026.03.010_bib0029","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/annonc\/mdv187","article-title":"2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer","volume":"26","author":"Eberhardt","year":"2015","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.03.010_bib0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jmrs.756","article-title":"A systematic review of brain metastases from lung cancer using magnetic resonance neuroimaging: clinical and technical aspects","volume":"71","author":"Ghaderi","year":"2024","journal-title":"J Med Radiat Sci"},{"issue":"11","key":"10.1016\/j.clbc.2026.03.010_bib0031","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO\u2013ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2026.03.010_bib0032","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"issue":"Suppl 5","key":"10.1016\/j.clbc.2026.03.010_bib0033","first-page":"v52","article-title":"Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies","volume":"3","author":"Myall","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"31","key":"10.1016\/j.clbc.2026.03.010_bib0034","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1200\/JCO.20.00505","article-title":"Brigatinib versus Crizotinib in advanced ALK inhibitor-naive ALK-positive non-small cell lung cancer: second interim analysis of the phase III ALTA-1L trial","volume":"38","author":"Camidge","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2026.03.010_bib0035","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1200\/JCO.2018.78.3118","article-title":"CNS response to Osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"36","author":"Reungwetwattana","year":"2018","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clbc.2026.03.010_bib0036","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1093\/annonc\/mdy405","article-title":"Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study","volume":"29","author":"Gadgeel","year":"2018","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2026.03.010_bib0037","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/neuonc\/noaf018","article-title":"Phase II trial of brain MRI surveillance in stage IV breast cancer","volume":"27","author":"Ahmed","year":"2025","journal-title":"Neuro Oncol"},{"issue":"29","key":"10.1016\/j.clbc.2026.03.010_bib0038","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1200\/JCO-25-00356","article-title":"Brain imaging surveillance for patients with metastatic breast cancer: a randomized clinical trial is required to guide practice","volume":"43","author":"Jerzak","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2026.03.010_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103756","article-title":"6th and 7th international consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)","volume":"76","author":"Cardoso","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2026.03.010_bib0040","unstructured":"National Comprehensive Cancer Network. Breast cancer (Version 1, 2026) 2026. Accessed February 19, 2026 Available at: https:\/\/guidelines.nccn.org\/guidelines\/Breast1_2026."},{"issue":"12","key":"10.1016\/j.clbc.2026.03.010_bib0041","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO Clinical Practice guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Committee","year":"2021","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.clbc.2026.03.010_bib0042","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.22.00520","article-title":"Management of advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: ASCO guideline update","volume":"40","author":"Ramakrishna","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682092600042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682092600042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:43:42Z","timestamp":1778154222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152682092600042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S152682092600042X"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.03.010","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subtype-Specific Risk and Temporal Dynamics of Brain Metastases in Metastatic Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}